BioVie Inc. (BIVI) vs Cytosorbents Corporation (CTSO)
A side-by-side comparison of BioVie Inc. and Cytosorbents Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIVI
BioVie Inc.
$1.44HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CTSO
Cytosorbents Corporation
$3.97HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BIVI vs CTSO
growth of $100 · dividends reinvested · last 10yBIVI -100.0% (-54.3%/yr)CTSO -96.7% (-28.9%/yr)CTSO compounded faster over this window
Log scale — wide-divergence pair
BIVI CTSO
BIVI vs CTSO: by the numbers
- •CTSO is the larger company ($12M vs $11M market cap).
- •Both run net losses; BIVI's is the smaller (0.00% vs -48.94% net margin).
Metrics side by side
Valuation
| Metric | BIVI | CTSO |
|---|---|---|
| P/S ratio | N/A | 0.33 |
| P/B ratio | 1.06 | N/A |
Profitability
| Metric | BIVI | CTSO |
|---|---|---|
| Gross margin | 0.00% | 71.61% |
| Operating margin | 0.00% | -33.37% |
| Net margin | 0.00% | -48.94% |
| ROE | -214.92% | N/A |
| ROIC | -216.67% | -43.31% |
Growth (annualized)
| Metric | BIVI | CTSO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -3.17% |
| Total return CAGR (5Y) | -70.37% | -52.26% |
Frequently asked
- How have BIVI and CTSO total returns compared?
- Over the past 10 years, BIVI delivered -54.09% and CTSO delivered -28.72% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.